CoolSculpting
CoolSculpting is an FDA-cleared, non-invasive body contouring brand that uses proprietary cryolipolysis (fat-freezing) technology to permanently eliminate treated fat cells in 9 body areas. It serves adult consumers seeking stubborn-fat reduction and is delivered through a certified provider network coordinated via the Allē loyalty and payments platform, under AbbVie ownership.
- Company typePrivate
- Founded2009
- HeadquartersPleasanton, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingHardware or Manufacturing
What CoolSculpting does
CoolSculpting is a medical-device brand operating in non-invasive aesthetic body contouring. Its core technology is proprietary cryolipolysis — controlled cooling that crystallizes and ruptures subcutaneous fat cells while preserving surrounding tissue, with built-in temperature sensors that automatically halt the system if skin temperature drifts out of safe range. The portfolio centers on the CoolSculpting and CoolSculpting Elite systems (FDA-cleared for 9 body areas: abdomen, flanks, submental/submandibular, thighs, upper arms, back fat, bra fat, banana roll), the complementary CoolTone magnetic muscle stimulation device, and the Allē patient loyalty and payment platform.
Revenue is generated transactionally: each treatment is priced per-area via consultation, patients typically require at least 2 sessions per area, and pricing is opaque / quote-based. Demand is driven direct-to-consumer through coolsculpting.com and the Allē app (education, before-and-after galleries, testimonial content, loyalty rewards), while delivery is fulfilled exclusively through a certified provider network of plastic surgeons, dermatologists, and medical spas surfaced via the Allē Directory. The Allē platform also integrates Cherry (0% APR-eligible installment financing) and cross-portfolio point earning with sibling Allergan/Aesthetics brands (JUVÉDERM fillers, SkinMedica skincare).
The brand originated with Allergan, was acquired by AbbVie in 2020, and operates today as a brand within AbbVie's Allergan Aesthetics portfolio rather than as an independent company; revenue, headcount, and financial performance are not disclosed at the CoolSculpting brand level.
CoolSculpting firmographics
Firmographics- Name
- CoolSculpting
- Legal name
- CoolSculpting (brand owned by AbbVie)
- Website
- https://coolsculpting.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CoolSculpting is an FDA-cleared, non-invasive body contouring brand that uses proprietary cryolipolysis (fat-freezing) technology to permanently eliminate treated fat cells in 9 body areas. It serves adult consumers seeking stubborn-fat reduction and is delivered through a certified provider network coordinated via the Allē loyalty and payments platform, under AbbVie ownership.
- Ownership category
- akta.pro rank
CoolSculpting industry classification
Industry- Product category
- Medical Aesthetic Devices
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hot/Cold Therapy Services (Cryotherapy/Ice Baths) (HSALAFAH)
- akta.pro secondary industry
- Cryotherapy Services (HSADAKAE)
Keywords
Where CoolSculpting is headquartered
LocationHeadquarters
- HQ city
- Pleasanton
- HQ country
- United States
- HQ region
- North America
Markets served
CoolSculpting business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Marketing or Sales, Technology or R&D, Supply Chain, Personnel, Operations
Revenue model
- Treatment Procedures: Revenue generated from CoolSculpting and CoolSculpting Elite cryolipolysis treatment sessions. Pricing varies based on treatment areas, number of sessions, and individual patient goals. Patients typically require at least 2 treatment sessions for desired results.
- Allē Loyalty Program: Points-based loyalty program where patients earn points on eligible treatments and redeem for savings on future procedures. 100 points equals $10 off eligible treatments and products.
- Payment Plans: Partnership with Cherry to offer installment payment plans allowing patients to pay over time. APR starts as low as 0% for eligible patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Treatment sessions are priced per area based on personalized consultation |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
CoolSculpting product offering
Product offeringCore offering
CoolSculpting develops and markets FDA-cleared cryolipolysis (fat-freezing) treatment systems and related medical aesthetic devices that are administered through certified healthcare providers to permanently eliminate stubborn fat in 9 body areas without surgery. Its portfolio includes CoolSculpting® and CoolSculpting® Elite fat-reduction systems and the CoolTone® magnetic muscle stimulation device, supported by the Allē consumer loyalty and payment platform. Revenue is generated through device and treatment-related sales delivered via a global certified provider network.
Product overview
CoolSculpting offers a portfolio of body contouring products centered on cryolipolysis technology. The core product line includes CoolSculpting® (the original FDA-cleared fat-freezing treatment) and CoolSculpting® Elite (the advanced version with improved applicators), both using controlled cooling to permanently eliminate treated fat cells. Complementary to these is CoolTone®, an FDA-cleared magnetic muscle stimulation device for toning and firming muscles. The company also operates Allē, a proprietary loyalty and payment program that integrates with third-party payment provider Cherry for financing options. The portfolio targets 9 body areas for fat reduction and supports muscle toning for abdomen, buttocks, and thighs.
Differentiator
Problem solved
Functional benefit
Brands
- CoolTone: FDA-cleared muscle toning device that strengthens, tones, and firms the abdomen, buttocks, and thigh muscles using magnetic muscle stimulation.
Products and services
- CoolSculpting® FDA-cleared cryolipolysis (fat-freezing) treatment that permanently eliminates up to 20–25% of treated fat cells in 9 body areas (submental, submandibular, thigh, abdomen, flank, bra fat, back fat, banana roll, upper arm) without surgery or downtime. Delivered to adult patients (18+) by certified healthcare providers listed in the Allē Directory.
- CoolSculpting® Elite Advanced FDA-cleared version of the CoolSculpting system with improved applicator cup design for better tissue draw and more comprehensive treatment coverage of visible fat bulges in the same 9 FDA-cleared body areas. Delivered to patients by certified providers.
- CoolTone® FDA-cleared magnetic muscle stimulation device that strengthens, tones, and firms abdomen, buttocks, and thigh muscles using involuntary muscle contractions, complementing CoolSculpting fat reduction as a body contouring offering.
- Allē CoolSculpting's proprietary points-based loyalty and patient engagement platform (with iOS and Android apps) that lets patients earn points on eligible CoolSculpting treatments, JUVÉDERM fillers, and SkinMedica products, redeem points for savings (100 points = $10 off), discover seasonal offers, and access Cherry-powered installment payment plans.
Quantifiable outcome
- Up to 20-25% of treated fat permanently eliminated per treatment area
- +4 more outcomes
Companies that use CoolSculpting
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
CoolSculpting technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature3 records
CoolSculpting partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- CherrycoreCherry provides payment plan infrastructure enabling CoolSculpting patients to pay for treatments over time in flexible monthly installments. Offers APR starting at 0% with no hard credit checks and no hidden fees. Integrated into the Allē platform for seamless patient financing.
- JUVÉDERM Collection of FillerscoreJUVÉDERM injectable gel fillers are featured in the Allē loyalty program as eligible products for earning points. This cross-portfolio partnership allows patients to earn and redeem points across multiple aesthetic treatments.
- SkinMedicacoreSkinMedica skincare products are part of the Allē loyalty program, allowing patients to earn points on purchases and redeem for savings across both CoolSculpting treatments and skincare products.
- Allē Provider NetworkcoreNetwork of certified healthcare providers (plastic surgeons, dermatologists, medical spas) who administer CoolSculpting treatments. Providers are listed in the Allē Directory and participate in the loyalty program, enabling patients to find specialists and earn points on treatments.
- BodifyminorMedical aesthetics practice credited for patient photography in the before-and-after gallery for banana roll treatment area. Operated by Steven Sorr, NMD.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
CoolSculpting competitors and assessment
Company assessmentDirect peers
- BTL Industries: Private medical-aesthetic device company behind Emsculpt NEO and Vanquish, which compete head-to-head with CoolSculpting/CoolTone for non-invasive fat reduction and muscle-toning consults in the same provider channel.
- Sciton: Private aesthetics/laser manufacturer whose body-contouring platforms compete with CoolSculpting for the same energy-based body shaping indication in dermatology and plastic-surgery practices.
- InMode: Public aesthetics device maker whose BodyTite, Evolve, and EvolveX platforms overlap directly with CoolSculpting and CoolTone for body contouring and muscle toning in clinics and med spas.
- Cutera: Public aesthetics device company selling truSculpt iD and truSculpt flex, which compete with CoolSculpting Elite on non-invasive body contouring through the same dermatologist and med-spa accounts.
- Cynosure (Hologic): Aesthetics/laser subsidiary of Hologic that markets SculpSure, a non-invasive laser lipolysis device positioned as a direct alternative to CoolSculpting in plastic-surgery and med-spa offices.
- Solta Medical (Bausch Health): Bausch Health subsidiary that markets Liposonix and Thermage, both non-invasive body-contouring/energy-based devices sold into the same physician and med-spa channel as CoolSculpting.
Others
- SkinCeuticals (L'Oréal Dermatological Beauty): Physician-dispensed skincare brand adjacent to the same aesthetics patient and provider ecosystem — competing for post-procedure skincare wallet alongside CoolSculpting's SkinMedica brand.
Broad incumbents
- Galderma: Major aesthetics and dermatology player (Restylane, Sculptra, skin-care lines) that overlaps with CoolSculpting's Allergan Aesthetics counterpart and competes for the same elective-aesthetic patient relationship, though it does not sell a cryolipolysis device.
- Merz Aesthetics: Incumbent aesthetics portfolio (Ultherapy, Radiesse, Belotero) that competes for the same elective-aesthetics patient wallet and the same physician channels, even though it does not directly compete in cryolipolysis.
Emerging players
- Evolus: Pure-play aesthetics challenger behind Jeuveau (botulinum toxin), operating in overlapping physician accounts and elective-aesthetic patient flow that CoolSculpting providers also serve.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CoolSculpting social profiles
Digital presenceCoolSculpting compliance and trust
Trust signalCompliance2 records
CoolSculpting financial estimates
Financial estimateRevenue estimate
Valuation estimate
CoolSculpting leadership team
Management profileNumber of profiles
CoolSculpting subsidiaries and ownership
Company hierarchySubsidiaries1 record
CoolSculpting funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CoolSculpting M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CoolSculpting
What does CoolSculpting do?
CoolSculpting develops and markets FDA-cleared cryolipolysis (fat-freezing) treatment systems and related medical aesthetic devices that are administered through certified healthcare providers to permanently eliminate stubborn fat in 9 body areas without surgery. Its portfolio includes CoolSculpting® and CoolSculpting® Elite fat-reduction systems and the CoolTone® magnetic muscle stimulation device, supported by the Allē consumer loyalty and payment platform. Revenue is generated through device and treatment-related sales delivered via a global certified provider network.
Is CoolSculpting a public or private company?
CoolSculpting is a private company. It is classified as corporate owned and is currently operating.
When was CoolSculpting founded?
CoolSculpting was founded in 2009. It employs 501 to 1,000 people.
Where is CoolSculpting based?
CoolSculpting is headquartered in Pleasanton, United States, in the North America region.
How does CoolSculpting make money?
Three revenue lines are on record. Treatment Procedures are the primary driver. The others are allē Loyalty Program and payment Plans.
Who are CoolSculpting's main competitors?
Direct peers on record are BTL Industries, Sciton, InMode, Cutera, Cynosure (Hologic) and Solta Medical (Bausch Health). SkinCeuticals (L'Oréal Dermatological Beauty) is listed as an others. Broad incumbents are Galderma and Merz Aesthetics. Evolus is listed as an emerging player.
Does CoolSculpting have an API?
No public API is recorded for CoolSculpting.
What industry is CoolSculpting in?
CoolSculpting's product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HSALAFAH, Hot/Cold Therapy Services (Cryotherapy/Ice Baths), with a secondary code of HSADAKAE, Cryotherapy Services. Its SIC code is 3845.